Finance

Lists
Why is AEON down 3.79%?
Dive Deeper
AEON:NYSEAMERICAN
Aeon Biopharma Inc
$0.28
-3.79%
(-0.011) 1D
$0.26
-6.06% (-0.017)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AEON...
Open
$0.30
High
$0.30
Low
$0.26
Mkt. cap
13.92M
Avg. vol.
14.44M
Volume
3.23M
52-wk high
$1.45
52-wk low
$0.18
EPS
-$3.58
Beta
0.69
Shares outstanding
49.88M
No. of employees
8
Open
$0.30
High
$0.30
Low
$0.26
Mkt. cap
13.92M
Avg. vol.
14.44M
Volume
3.23M
52-wk high
$1.45
52-wk low
$0.18
EPS
-$3.58
Beta
0.69
Shares outstanding
49.88M
No. of employees
8
News stories
From web sources and news partners
Profile
Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology. Wikipedia
About Aeon Biopharma Inc
CEOMurthy Simhambhatla
Employees8
Founded2013
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteaeonbiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
597.00K
1.61M
2.03M
2.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.33M
3.49M
3.90M
2.99M
Operating expense
2.93M
5.10M
5.94M
5.93M
Total operating expenses
2.93M
5.10M
5.94M
5.93M
Operating income
-2.93M
-5.10M
-5.94M
-5.93M
Other non operating income
-168.00K
-14.08M
2.94M
4.98M
EBT including unusual items
-4.54M
-37.14M
-11.79M
-1.16M
EBT excluding unusual items
-3.10M
-19.18M
-2.99M
-952.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.54M
-37.14M
-11.79M
-1.16M
Net profit margin
-
-
-
-
Earnings per share
-0.39
-3.72
-0.25
-0.02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.91M
-5.08M
-5.92M
-5.91M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps